C.Q. Pharmaceutical Holding Co., Ltd.

Shenzhen Stock Exchange 000950.SZ

C.Q. Pharmaceutical Holding Co., Ltd. Price to Earnings Ratio (P/E) on January 14, 2025: 13.05

C.Q. Pharmaceutical Holding Co., Ltd. Price to Earnings Ratio (P/E) is 13.05 on January 14, 2025, a 3.15% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

C.Q. Pharmaceutical Holding Co., Ltd. 52-week high Price to Earnings Ratio (P/E) is 16.62 on December 20, 2024, which is 27.29% above the current Price to Earnings Ratio (P/E).
C.Q. Pharmaceutical Holding Co., Ltd. 52-week low Price to Earnings Ratio (P/E) is 11.38 on February 02, 2024, which is -12.85% below the current Price to Earnings Ratio (P/E).
C.Q. Pharmaceutical Holding Co., Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is 13.50.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Shenzhen Stock Exchange: 000950.SZ

C.Q. Pharmaceutical Holding Co., Ltd.

CEO	Mr. Wei Liu
IPO Date	Sept. 16, 1999
Location	China
Headquarters	No 1, Datong Road
Employees	14,485
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

C.Q. Pharmaceutical Holding Co., Ltd. distributes pharmaceutical products. Chongqing Medicines Co., Ltd. was formerly known as Southwest Branch of China Medicine Company. The company was founded in 1950 and is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. develops, manufactures, and distributes pharmaceuticals. The company is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. operates as a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company

Key trends

Past 5 years